Decreased MALL expression negatively impacts colorectal cancer patient survival

Xiaoliang Wang1, Junwei Fan1, Fudong Yu1

  • 1Department of General Surgery, Shanghai First People's Hospital, Medical College, Shanghai Jiao Tong University, Shanghai, China.

Oncotarget
|March 19, 2016
PubMed

Insights

Reduced MALL expression is linked to poorer outcomes in colon cancer patients, including increased metastasis and decreased survival. MALL may act as a tumor suppressor in colorectal cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MALL (mucin-associated لیگ্যান্ড) is a gene implicated in cellular processes.
  • Its role in colorectal cancer (CRC) progression and patient prognosis remains unclear.

Purpose of the Study:

  • To investigate the association between MALL expression and colon cancer progression.
  • To evaluate the impact of MALL expression on patient survival in colorectal cancer.

Main Methods:

  • Quantitative analysis of MALL mRNA and protein expression in tumor versus normal tissues.
  • Assessment of Loss of Heterozygosity (LOH) and methylation of MALL in tumor tissues.
  • Correlation analysis of MALL expression with clinical parameters like invasion, recurrence, metastasis, and survival.
  • In vitro studies involving MALL overexpression in colon cancer cell lines (HCT116, SW480) to assess proliferation and migration.

Main Results:

  • MALL mRNA and protein expression were significantly reduced in 70-75% of colon and rectal cancer tissues compared to normal tissues.
  • Increased LOH and methylation of MALL were observed in tumor tissues.
  • Reduced MALL expression correlated significantly with vascular invasion, disease recurrence, metastasis, and mortality (P ≤ 0.027).
  • Patients with MALL-negative tumors exhibited significantly decreased overall survival (OS) and disease-free survival (DFS) (P < 0.008 and P < 0.011, respectively).
  • Overexpression of MALL suppressed HCT116 and SW480 cell proliferation and inhibited HCT116 cell migration.

Conclusions:

  • MALL expression is significantly downregulated in colorectal cancer tissues.
  • Reduced MALL expression is associated with aggressive tumor features and poorer patient survival (OS and DFS).
  • MALL may function as a tumor suppressor in colorectal cancer, and its reduced expression negatively impacts patient prognosis.